// App-Quantinova.ai

TCT-55 : Major Adverse Cardiac Events Associated With Discontinuation Of Clopidogrel Treatment Within The First Year After Coronary Stent Implantation In Western Denmark

Researchers

Presenter

  • Michael Maeng

Principal Investigators

  • Troels Thim

  • Gro Chisholm

  • Leif Thuesen

  • Martin Johansen

  • Morten Schmidt

  • Henrik T Sorensen

  • Lisette Okkels Jensen

  • Per Thayssen

  • Hans-Henrik Tilsted

  • Hans Erik Botker

  • Jens Lassen

Medical Centers

  • University Hospital of Aalborg, Aalbog, Denmark

  • Aarhus University Hospital, Aarhus, Denmark

  • Department of Urology, Aarhus University Hospital, Skejby Sygehus, Aarhus, Denmark

  • Aarhus University Hospital, Aarhus, Denmark

  • Aarhus University Hospital, Aarhus, Denmark

  • Aarhus University Hospital, Aarhus, Denmark

  • Skejby University Hospital, Skejby, Aarhus, Denmark

  • Department of Urology, Aarhus University Hospital, Skejby Sygehus, Aarhus, Denmark

  • Odense University Hospital, Odense, Denmark

  • Department of Oncology, Odense University Hospital, Odense, Denmark

Locations

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved